Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Richard Marshall
Biotech
Investment
Investment
M42 and Juvenescence collaborate on AI-enabled longevity drugs
Features
Investment
Investment
Videos
Juvenescence: Think aging up, rather than disease down
Investment
Juvenescence appoints Dr Richard Marshall CBE as CEO
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
This field is hidden when viewing the form
Contact Source
